Simplify Asset Management’s Connect Biopharma Holdings CNTB Stock Holding History

Simplify Asset Management’s Portfolio CNTB Stock Details CNTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-51,475	Closed	-$135K	–	146
2026 Q1	$135K	Buy	+51,475	New	+$134K	﹤0.01%	139

Other funds holding CNTB

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Simplify Asset Management's CNTB Position: Q2 2026 in Review

Simplify Asset Management sold out of Connect Biopharma Holdings (CNTB) in Q2 2026, closing a stake of 51,475 shares — an estimated $135K sold.

Simplify Asset Management first reported a position in CNTB in Q1 2026 and held it in 1 quarter. The position peaked at $135K in Q1 2026. 2 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

Simplify Asset Management reported no remaining Connect Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
Simplify Asset Management sold 51,475 Connect Biopharma Holdings shares in Q2 2026, an estimated $135K.
Simplify Asset Management first reported a position in Connect Biopharma Holdings in Q1 2026 and held it in 1 quarter.
Simplify Asset Management's Connect Biopharma Holdings position peaked at $135K in Q1 2026.
2 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.